# Intralumenal Effects on Cholesterol Absorption/Synthesis

> **NCT00328211** · NA · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 35 (actual)

## Conditions studied

- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** Bile Acids (Cholic, Ursodeoxycholic, Chenodeoxycholic)
- **DIETARY_SUPPLEMENT:** Sphingomyelin
- **OTHER:** C13 Stable isotope of Cholesterol

## Key facts

- **NCT ID:** NCT00328211
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2020-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00328211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00328211, "Intralumenal Effects on Cholesterol Absorption/Synthesis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00328211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*